secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sight Sciences, Inc. (SGHT)
CIK:        0001531177
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-269525
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sight Sciences Q3 revenue $19.9M, raises FY25 guidance; promotes COO and CFO
----------------------------------------------------------------------------

- Surgical Glaucoma revenue $19.7M (+6% YoY); Dry Eye revenue $0.2M (-88%) as company focuses on reimbursed access.
- Net loss narrowed to $8.2M ($0.16 loss per share) from $11.1M loss in Q3 2024.
- Raises FY2025 revenue guidance to $76-78M (from $72-76M); reduces adj. op. expense guidance to $90-92M.
- Promoted Alison Bauerlein to COO from CFO, James Rodberg to CFO, effective Nov 5, 2025.
- Board members Becker and Rogers resigned; board size reduced from 9 to 7.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531177/000119312525269525/0001193125-25-269525-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531177/000119312525269525/sght-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-269525

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer